AI in the pharmaceutical industry – is your data a strategic asset or a hidden risk?

Thursday, 06 Nov 2025

4:00 PM - 4:45 PM

Overview
Speakers

How AI trends are shaping strategic decisions in the pharmaceutical industry
High-value use cases, including AI-driven processing of large-scale pharmaceutical documentation
How responsible AI use in GxP-critical processes can mitigate compliance risk in the US market

Featuring:

Kevin Craine, Host, AI Talk

Julie Daves, President & Principal Consultant, JVD Pharmaceutical Consulting, LLC

Tomas Van Dorpe, Pre-Sales Architect, Cegeka

Artificial intelligence is reshaping how pharmaceutical companies innovate, compete and remain compliant. But with opportunity comes risk – especially when sensitive data and regulated processes are involved.

How can pharma leaders harness AI responsibly to unlock value, accelerate decision-making, and safeguard compliance?

Join our next episode of AI Talk with Kevin Craine, who hosts a panel discussion where we’ll explore:

How AI trends are shaping strategic decisions in the pharmaceutical industry
High-value use cases, including AI-driven processing of large-scale pharmaceutical documentation
How responsible AI use in GxP-critical processes can mitigate compliance risk in the US market

Join this panel to find out more about how AI is transforming innovation and risk management within the pharmaceutical industry.